PDDPF News and Press, Medexus Pharmaceuticals Inc From 06/17/20

MONTREAL, June 17, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Tuesday, June 23, 2020 to discuss the Company ...

TORONTO and CHICAGO and MONTREAL, June 03, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX-V: MDP, OTCQB: PDDPF) today announced that it will be presenting at the 2020 Virtual Summer Summit being held on June 9 th -12 th ...

TORONTO and CHICAGO and MONTREAL, May 22, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX-V: MDP, OTCQB: PDDPF) today provided an update on its business in light of the recent transformative acquisition of the commercial ...

TORONTO, CHICAGO and MONTREAL, May 07, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSX-V: MDP, OTCQB: PDDPF) today announced that the Company has entered into a definitive credit agreement with a syndicate of lender...

MONTREAL, April 08, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) is pleased to announce that the pan-Canadian Pharmaceutical Alliance (pCPA) price negotiations for Triamcinolone Hexacetonide ...

TORONTO, CHICAGO and MONTREAL, March 23, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSX-V: MDP, OTCQB: PDDPF) today announced that it will be presenting at the 2020 Spring Investor Summit being held on March 25th-2...

TORONTO, CHICAGO and MONTREAL, March 23, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSX-V: MDP, OTCQB: PDDPF) today provided an update to its shareholders reaffirming the strength of its business and outlining the ...

Acquisition Expected to be Immediately Accretive to Adjusted EBITDA 1 Announces US$20 Million Credit Facility with MidCap Financial TORONTO and CHICAGO and MONTREAL, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“ Medexus ” or the “ Company &...

Medexus Pharmaceuticals ( OTCPK:PDDPF ): Q3 net loss of C$2.6M More news on: Medexus Pharmaceuticals Inc, Earnings news and commentary, Healthcare stocks news, , Read more ...

Q3 2020 Metoject ®  unit market demand increased 88% 1 ; Rupall ™ unit market demand increased 62% 2 ; and Rasuvo ®  unit market demand increased 8% 3 Management to host conference call at 8:00 AM ET on Wednesday, February 19, 2020 TORONT...